Ozempic may cause rare blindness (Credits: iStock)
\n\nPopular diabetes and weight-loss medications, including Ozempic, Wegovy and Mounjaro, are facing fresh safety scrutiny after the US Food and Drug Administration (FDA) flagged a potential risk of a rare eye condition that can cause sudden and permanent vision loss. The regulator has directed manufacturers of GLP-1 receptor agonist medicines to include new safety information in the 'Warnings and Precautions' section of their drug labels.
\n\nThe condition in question is called Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). It occurs when blood flow to the optic nerve, which carries visual information from the eye to the brain, is reduced. This can result in sudden, painless vision loss, usually affecting one eye. In some cases, the damage is permanent.
\n\nUnlike several common eye conditions, NAION may develop without pain or obvious warning signs. Some people notice a sudden deterioration in their vision when they wake up. Symptoms can include blurred or hazy vision, blind spots, missing portions of the visual field and changes in colour perception. The FDA has advised patients experiencing sudden vision changes or other symptoms associated with NAION to contact their healthcare professional immediately. Prompt assessment by an ophthalmologist is important.
\n\nThe…
Original source: https://www.timesnownews.com/lifestyle
